Role of Macrophages in Host Resistance to Group A Streptococci

Infection and Immunity

Volumn 72, Issue 5, 2004, Pages 2956-2963

  Goldmann, Oliver ^a   Rohde, Manfred ^a   Chhatwal, Gursharan Singh ^a   Medina, Eva ^a  

^a HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; ELECTRON MICROSCOPY; FEMALE; HOST RESISTANCE; IMMUNOFLUORESCENCE TEST; IN VIVO STUDY; MACROPHAGE; MOUSE; NONHUMAN; PATHOGENESIS; PHAGOCYTE; PRIORITY JOURNAL; STREPTOCOCCUS GROUP A; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PYOGENES; SURVIVAL;

ANIMALS; CARRAGEENAN; FEMALE; GADOLINIUM; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED BALB C; MICROSCOPY, ELECTRON; PHAGOCYTOSIS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES; TIME FACTORS;

EID: 2142768811     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.72.5.2956-2963.2004     Document Type: Article

References (38)

1. Adding, L. C., G. L. Bannenberg, and L. E. Gustafsson. 2001. Basic experimental studies and clinical aspects of gadolinium sails and chelates. Cardiovasc. Drug Rev. 19:41-56.
2. Aderem, A. 2003. Phagocytosis and the inflammatory response. J. Infect. Dis. 187(Suppl. 2):S340-S345.
3. Aderem, A., and D. M. Underbill. 1999. Mechanisms of phagocytosis in macrophages. Annu. Rev. Immunol. 17:593-623.
4. Albanyan, E. A., and M. S. Edwards. 2000. Lectin site interaction with capsular polysaccharide mediates nonimmune phagocytosis of type III group B streptococci. Infect. Immun. 68:5794-5802.
5. Cone, L. A., D. R. Woodard, P. M. Schlievert, and G. S. Tomory. 1987. Clinical and bacteriologic observations of a toxic shock-like syndrome due to Streptococcus pyogenes. N. Engl. J. Med. 317:146-149.
6. Debrick, J. E., P. A. Campbell, and U. D. Staerz. 1991. Macrophages as accessory cells for class 1 MHC-restricted immune responses. J. Immunol. 147:2846-2851.
7. Efstratiou, A. 2000. Group A streptococci in the 1990s. J. Antimicrob. Chemother. 45(Suppl.):3-12.
8. Fischetti, V. A. 1989. Streptococcal M protein: molecular design and biological behaviour Clin. Microbiol. Rev. 2:285-314.
9. Goldmann, O., G. S. Chhatwal, and E. Medina. 2003. Immune mechanisms underlying host susceptibility to infection with group A streptococci. J. Infect. Dis. 187:854-861.
10. Holm, S. E. 1996. Invasive group A streptococcal infections. N. Engl. J. Med. 335:590-591.
11. Hume, D. A., L. L. Ross, S. R. Himes, R. T. Sasmono, C. A. Wells, and T. Ravasi. 2002. The mononuclcar phagocyte system revisited. J. Leukoc. Biol. 72:621-627.
12. Jadus, M. R., C. C. Williams, M. D. Avina, M. Ly, S. Kim, Y. Liu, R. Narasaki, C. A. Lowell, and H. T. Wepsic. 1998. Macrophages kill T9 glioma tumor cells bearing the membrane isoform of macrophage colony stimulating factor through a phagocytosis-dependent pathway. J. Immunol. 160:361-368.
13. Ji, Y., L. McLandsborough, A. Kondagunta, and P. P. Cleary. 1996. C5a peptidase alters clearance and trafficking of group A streptococci by infected mice. Infect. Immun. 64:503-510.
14. Kaplan, E. L. 1991. The resurgence of group A streptococcal infections and their sequelae. Eur. J. Clin. Microbiol. Infect. Dis. 10:55-57.
15. Keshav, S., L. P. Chung, and S. Gordon. 1990. Macrophage products in inflammation. Diagn. Microbiol. Infect. Dis. 13:439-447.
16. Lancefield, R. C. 1962. Current knowledge of type-specific M antigens of group A streptococci. J. Immunol. 89:307-313.
17. Lei, B., F. R. DeLeo, N. P. Hoe, M. R. Graham, S. M. Mackie, R. L. Cole, M. Liu, H. R. Hill, D. E. Low, M. J. Federle, J. R. Scott, and J. M. Musser. 2001. Evasion of human innate and acquired immunity by a bacterial homolog of CD11b that inhibits opsonophagocytosis. Nat. Med. 7:1298-1305.
18. Medina, E., O. Goldmann, M. Rohde, A. Lengeling, and G. S. Chhatwal. 2001. Genetic control of susceptibility to group A streptococcal infection in mice. J. Infect. Dis. 184:846-852.
19. Miettinen, M., A. Lehtonen, I. Julkunen, and S. Matikainen. 2000. Lactobacilli and Streptococci activate NF-kappa B and STAT signaling pathways in human macrophages. J. Immunol. 164:3733-3740.
20. Mork, T., and R. E. Hancock. Mechanisms of nonopsonic phagocytosis of Pseudomonas aeruginosa. Infect. Immun. 61:3287-3293.
21. Muller, W. A. 2003. Leukocyte-endothelial-cell interactions in leukocyte transmigration and the inflammatory response. Trends Immunol. 24:327-334.
22. Musher, D. M., R. J. Hamill, C. E. Wright, J. E. Clarridge, and C. M. Ashton. 1996. Trends in bacteremic, infection due to Streptococcus pyogenes (group A streptococcus), 1986-1995. Emerg. Infect. Dis. 2:54-56.
23. Nathan, C. F. 1987. Secretory products of macrophages. J. Clin. Investig. 79:319-326.
24. Ofek, I., J. Goldhar, Y. Keisari, and N. Sharon. 1995. Nonopsonic phagocytosis of microorganisms. Annu. Rev. Microbiol. 49:239-276.
25. Roland, C. R., Y. Nakafusa, and M. W. Flye. 1999. Gadolinium chloride inhibits lipopolysaccharide-induced mortality and in vivo prostaglandin E2 release by splenic macrophages. J. Gastrointest. Surg. 3:301-307.
26. Sansonetti, P. 2001. Phagocytosis of bacterial pathogens: implications in the host response. Semin. Immunol. 13:381-390.
27. Shi, J., Y. Kokubo, and K. Wake. 1998. Expression of P-selectin on hepatic endothelia and platelets promoting neutrophil removal by liver macrophages. Blood 92:520-528.
28. Sosroseno, W., and E. Heminajeng. 2002. The role of macrophages in the induction of murine immune response to Actinobacillus actinomycetemcomitans. J. Med. Microbiol. 51:581-588.
29. Spurr, A. R. 1969. A low-viscosity epoxy resin embedding medium for electron microscopy. J. Ultrastruct. Res. 26:31-43.
30. Stevens, D. L., et al. 1989. Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A. N. Engl. J. Med. 321:1-7.
31. Suzuki, H., Y. Kurihara, M. Takeya, N. Kamada, M. Kataoka, K. Jishage, O. Ueda, H. Sakaguchi, T. Higashi, T. Suzuki, Y. Takashima, Y. Kawabe, O. Cynshi, Y. Wada, M. Honda, H. Kurihara, H. Aburatani, T. Doi, A. Matsumoto, S. Azuma, T. Noda, Y. Toyoda, H. Itakura, Y. Yazaki, T. Kodama, et al. 1997. A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection. Nature 386:292-296.
32. Thomas, C. A., Y. Li, T. Kodama, H. Suzuki, S. C. Silverstein, and J. El Khoury. 2000. Protection from lethal gram-positive infection by macrophage scavenger receptor-dependent phagocytosis. J. Exp. Med. 191:147-156.
33. Udono, H., D. L. Levey, and P. K. Srivastava. 1994. Cellular requirements for tumor-specific immunity elicited by heat shock proteins: tumor rejection antigen gp96 primes CD8+ T cells in vivo. Proc. Natl. Acad. Sci. USA 91:3077-3081.
34. Veckman, V., M. Miettinen, S. Matikainen, R. Lande, E. Giacomini, E. M. Coccia, and I. Julkunen. 2003. Lactobacilli and streptococci induce inflammatory chemokine production in human macrophages that stimulates Th1 cell chemotaxis. J. Leukoc. Biol. 74:395-402.
35. Wessels, M. R., A. E. Moses, J. B. Goldberg, and T. J. DiCesare. 1991. Hyaluronic acid capsule is a virulence factor for mucoid group A streptococci. Proc. Natl. Acad. Sci. USA 88:8317-8321.
36. Wexler, D. E., D. E. Chenoweth, and P. P. Cleary. 1985. Mechanism of action of the group A streptococcal C5a inactivator. Proc. Natl. Acad. Sci. USA 82:8144-9148.
37. Wright, S. D., and S. C. Silverstein. 1986. Overview: the function of receptors in phagocytosis, p. 41.1-41.14. In D. M. Weir (ed.), Cellular immunology. Blackwell Scientific Publications, Oxford, United Kingdom.
38. Yamazaki, K., T. Nguyen, and E. R. Podack. 1999. Cutting edge: tumor secreted heat shock-fusion protein elicits CD8 cells for rejection. J. Immunol. 163:5178-5182.